CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Medtronic ATS Medical, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Medtronic ATS Medical, Inc.
3905 Annapolis Lane N.
Suite 105
Phone: (763) 553-7736p:763 553-7736 Minneapolis, MN  55447  United States Ticker: ATSIATSI

This company was Merged or Acquired on 8/12/2010.
This company ceased filing statements with the SEC on 8/23/2010.
ATS Medical, Inc. (now known as Medtronic ATS Medical, Inc.) filed a Registration Withdrawal Request of its Form S-3 Registration Statement (File No. 333-33017) with the SEC on 8/19/2010. The Company has decided not to proceed with the offering covered by the Form at the time.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Medtronic ATS Medical, Inc., formerly ATS Medical, Inc. (ATS), develops, manufactures and markets medical devices for the treatment of structural heart disease. The Company’s product offerings are focused on heart valve therapy and the surgical treatment of cardiac arrhythmias. ATS Open Pivot Heart Valve was designed to improve upon existing mechanical heart valves by combining an open pivot design and other features with the accepted biocompatibility and durability of pyrolytic carbon. During the year ended December 31, 2009, sales of mechanical heart valves represented approximately 60% of the Company’s revenue.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
-Yes-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
7/3/201012/31/2009YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Michael D.Dale 50 8/12/2010 10/1/2002
President Michael J.Coyle 47 8/12/2010 8/12/2010
Chief Financial Officer, Vice President, Director Gary L.Ellis 53 8/12/2010 8/12/2010
9 additional Officers and Directors records available in full report.

Business Names
Business Name
3F Therapeutics, Inc.
ATS Acquisition Corp.
ATS Medical Belgium SPRL
5 additional Business Names available in full report.

General Information
Number of Employees: 321 (As of 12/31/2009)
Outstanding Shares: 81,596,406 (As of 8/6/2010)
Shareholders: 549
Stock Exchange: NASD
Federal Tax Id: 411595629
Fax Number: (763) 557-2244
Email Address: info@atsmedical.com


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, July 18, 2019